Skip to main content
Log in

Depression and nicotine: Preclinical and clinical evidence for common mechanisms

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Updated findings on the relationship between nicotine and depression are presented. Clinical and preclinical research on nicotine use and depression suggests that nicotine may have some properties in common with antidepressants. Updated findings involve the comorbidity of smoking and major depressive disorder (MDD), the influence of depression during withdrawal on failure to quit smoking, the course of MDD without nicotine and the neurobiology of smoking and depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Hughes JR, Hatsukami DK, Mitchell JE, et al.: Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986, 143:993–997.

    PubMed  CAS  Google Scholar 

  2. Glassman AH, Stetner F, Walsh T, et al.: Heavy smokers, smoking cessation, and clonidine: results of a double-blind randomized trial. JAMA 1988, 259:2863–2866.

    Article  PubMed  CAS  Google Scholar 

  3. Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8–19.

    PubMed  CAS  Google Scholar 

  4. Glassman AH, Covey LS, Dalack GW, et al.: Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993, 54:670–679.

    Article  PubMed  CAS  Google Scholar 

  5. Ginsberg D, Hall SM, Reus VI, et al.: Mood and depression diagnosis in smoking cessation. Exp Clin Psychopharmacology 1995, 3:389–395.

    Article  Google Scholar 

  6. Niaura R, Goldstein MG, Depue J: Fluoxetine, symptoms of depression, and smoking cessation [abstract]. Ann Behav Med 1995, 17(suppl):SO61.

    Google Scholar 

  7. Glassman AH, Helzer JE, Covey LS, et al.: Smoking, smoking cessation, and major depression. JAMA 1990, 264:1546–1549.

    Article  PubMed  CAS  Google Scholar 

  8. Anda RF, Williamson DF, Escobedo LG, et al.: Depression and the dynamics of smoking: a national perspective. JAMA 1990, 264:1541–1545.

    Article  PubMed  CAS  Google Scholar 

  9. Kendler KS, Neale MC, MacLean CJ, et al.: Smoking and major depression: a causal analysis. Arch Gen Psychiatry 1993, 50:36–43.

    PubMed  CAS  Google Scholar 

  10. Breslau N: Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet 1995, 25:95–101.

    Article  PubMed  CAS  Google Scholar 

  11. Brown C, Madden PA, Palenchar DR, et al.: The association between depressive symptoms and cigarette smoking in an urban primary care sample. Int J Psychiatry Med 2000, 30:15–26.

    Article  PubMed  CAS  Google Scholar 

  12. West RJ, Hajek P, Belcher M: Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med 1989, 19:981–985.

    Article  PubMed  CAS  Google Scholar 

  13. Covey LS, Glassman AH, Stetner F: Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990, 31:350–354.

    Article  PubMed  CAS  Google Scholar 

  14. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatry Association Press; 1994.

    Google Scholar 

  15. Kinnunen T, Doherty K, Militello FS, et al.: Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. J Counseling Clin Psychology 1996, 64:791–798.

    Article  CAS  Google Scholar 

  16. Pomerleau CS, Pomerleau OF: Euphoriant effects of nicotine in smokers. Psychopharmacology 1992, 108:460–465.

    Article  PubMed  CAS  Google Scholar 

  17. Salin-Pascual RJ, de la Fuente JR, Galicia-Polo L, et al.: Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 1995, 121:476–479.

    Article  PubMed  CAS  Google Scholar 

  18. Borrelli B, Niaura R, Keuthen NJ, et al.: Development of major depressive disorder during smoking-cessation treatment. J Clin Psychiatry 1996, 57:534–538.

    PubMed  CAS  Google Scholar 

  19. Covey LS, Glassman AH, Stetner F: Major depression following smoking cessation. Am J Psychiatry 1997, 154:263–265. Examined the incidence and predictors of major depression following successful smoking cessation treatment, with special attention to the incidence of past major depression. Three-month follow-up data showed that a history of major depression and persistent withdrawal symptoms independently predicted posttreatment major depression.

    PubMed  CAS  Google Scholar 

  20. Tsoh JY, Humfleet GL, Munoz RF, et al.: Development of major depression after treatment for smoking cessation. Am J Psychiatry 2000, 157:368–374.

    Article  PubMed  CAS  Google Scholar 

  21. Glassman AH, Covey LS, Stetner F, et al.: Smoking cessation and the course of major depression: a follow-up study. Lancet 2001, 357:1929–1932. Participants with a history of depression from a smoking cessation study were followed up in clinical interviews 3 and 6 months after the end of treatment. Smokers with a history of depression who abstain from smoking are at significantly increased risk of developing a new episode of major depression. This risk remains high for at least 6 months.

    Article  PubMed  CAS  Google Scholar 

  22. MacDermott AB, Role LW, Siegelbaum SA: Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci 1999, 22:443–485.

    Article  PubMed  CAS  Google Scholar 

  23. McGehee DS, Heath MJ, Gelber S, et al.: Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 1995, 269:1692–1696.

    Article  PubMed  CAS  Google Scholar 

  24. Westfall TC: Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacology 1974, 13:693–700.

    Article  PubMed  CAS  Google Scholar 

  25. Westfall TC, Grant H, Perry H: Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors. Gen Pharmacol 1983, 14:321–325.

    PubMed  CAS  Google Scholar 

  26. Mesulam MM: Structure and function of cholinergic pathways in the cerebral cortex, limbic system, basal ganglia, and thalamus of the human brain. In Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom F, Kupfer D. New York: Raven Press; 1995.

    Google Scholar 

  27. Matta SG, Fu Y, Valentine JD, Sharp BM: Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998, 23:103–113.

    Article  PubMed  CAS  Google Scholar 

  28. Levin ED, Simon BB: Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 1998, 138:217–230.

    Article  PubMed  CAS  Google Scholar 

  29. Robbins T, Everitt BJ: Arousal systems and attention. In The Cognitive Neurosciences. Edited by Gazzzaniga M. Cambridge, MA: MIT Press; 1995:703–720.

    Google Scholar 

  30. Muir, JL, Everitt BJ, Robbins TW: AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 1994, 14:2313–2326.

    PubMed  CAS  Google Scholar 

  31. Imperato AA, Mulas A, Di Chiara G: Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 1986, 132:337–338.

    Article  PubMed  CAS  Google Scholar 

  32. Corrigall WA, Coen KM: Nicotine maintains robust selfadministration in rats on a limited-access schedule. Psychopharmacology 1989, 99:473–478.

    Article  PubMed  CAS  Google Scholar 

  33. Pagliusi SR, Tessari M, DeVevey S, et al.: The reinforcing properties of nicotine are associated with a specific patterning of c-fos expression in the rat brain. Eur J Neurosci 1996, 8:2247–2256.

    Article  PubMed  CAS  Google Scholar 

  34. Pich EM, Pagliusi SR, Tessari M, et al.: Common neural substrates for the addictive properties of nicotine and cocaine. Science 1997, 275:83–86.

    Article  PubMed  CAS  Google Scholar 

  35. Yang ZJ, Blaha V, Meguid MM, et al.: Infusion of nicotine into the LHA enhances dopamine and 5-HT release and suppresses food intake. Pharmacol Biochem Behav 1999, 64:155–159.

    Article  PubMed  CAS  Google Scholar 

  36. Kenny PJ, File SE, Rattray M: Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 2000, 85:234–238.

    Article  PubMed  CAS  Google Scholar 

  37. Maggio R, Riva M, Vaglini F, et al.: Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. J Neural Transm 1997, 104:1113–1123.

    Article  PubMed  CAS  Google Scholar 

  38. Duman RS: Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998, 44:324–335.

    Article  PubMed  CAS  Google Scholar 

  39. Smith MA, Makino S, Kvetnansky R, Post RM: Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci 1995, 771:234–239.

    Article  PubMed  CAS  Google Scholar 

  40. Kenny PJ, File SE, Rattray M: Nicotine regulates 5-HT(1A) receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur J Neurosci 2001, 13:1267–1271.

    Article  PubMed  CAS  Google Scholar 

  41. Djuric VJ, Dunn E, Overstreet DH, et al.: Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiol Behav 1999, 67:533–537.

    Article  PubMed  CAS  Google Scholar 

  42. Semba J, Mataki C, Yamada S, et al.: Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats. Biol Psychiatry 1998, 43:389–391.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laje, R.P., Berman, J.A. & Glassman, A.H. Depression and nicotine: Preclinical and clinical evidence for common mechanisms. Curr Psychiatry Rep 3, 470–474 (2001). https://doi.org/10.1007/s11920-001-0040-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-001-0040-z

Keywords

Navigation